跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
superoxide dismutase
首页
药物
superoxide dismutase
superoxide dismutase
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antisense modulation of superoxide dismutase 1, soluble expression
US 7132530 B2
申请人: ISIS PHARMACEUTICALS INC
优先权: 2003
US
10 件公开
US 2005019915 A1
申请人: BENNETT C FRANK
优先权: 2003
US
siRNA targeting superoxide dismutase 1 (SOD1)
US 7632938 B2
申请人: DHARMACON INC
优先权: 2007
US
4 件公开
Superoxide dismutase variants and methods of use thereof
US 8460653 B2
申请人: CHEN DANICA
优先权: 2011
US
4 件公开
BACILLUS SPECIES STRAIN EXPRESSING SUPEROXIDE DISMUTASE, BACILLUS SPECIES STRAIN SPORE AND/OR SUPEROXIDE DISMUTASE, AND USE THEREOF FOR PREVENTING OR TREATING OF FIBROTIC DISEASE
EP 4595967 A1
申请人: HLB GENEX INC
优先权: 2022
CN
EP
US
3 件公开
RADIOPROTECTION BY INHIBITION OF SUPEROXIDE DISMUTASE 1
EP 4687863 A1
申请人: DEUTSCHES KREBSFORSCH
优先权: 2023
CN
EP
WO
3 件公开
POLYETHYLENE GLYCOLATED SUPEROXIDE DISMUTASE MIMETICS
US 2012301403 A1
申请人: SALVEMINI DANIELA
优先权: 2012
US
3 件公开
US 8217166 B2
申请人: SALVEMINI DANIELA
优先权: 2007
US
2 件公开
INHALANT COMPRISING MODIFIED SUPEROXIDE DISMUTASE
US 2011262420 A1
申请人: LTT BIO PHARMA CO LTD
优先权: 2008
CN
US
2 件公开
NUCLEIC ACID MOLECULES TARGETING SUPEROXIDE DISMUTASE 1 (SOD1)
EP 3862005 A1
申请人: PHIO PHARM CORP
优先权: 2015
EP
US
2 件公开
COMPOSITION CONTAINING NICKEL-SUPEROXIDE DISMUTASE AND THE LIKE USEFUL FOR HAIRCARE
US 2023277554 A1
申请人: WANG TZU LI
优先权: 2020
CN
US
2 件公开
Biomaterials modified with superoxide dismutase mimics
US 7445641 B1
申请人: PHARMACIA CORP
优先权: 2000
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈